Skip to search formSkip to main contentSkip to account menu

Pyridinolcarbamate

Known as: Pyricarbate, Pyridinolcarbamate [Chemical/Ingredient], 2,6-Pyridinedimethanol-bis-(N-methylcarbamate) 
A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1975
1975
The presence of IgG and β‐lipoprotein in thoracic and abdominal aortas of 33 rhesus monkeys under various conditions was observed… 
1975
1975
The hyperreactive arterial endothelial cells have been introduced in this paper. They are characterized by their ability to… 
Highly Cited
1973
Highly Cited
1973
  • T. Yoshizaki
  • Japanese Journal of Pharmacology
  • 1973
  • Corpus ID: 31236355
Abstract Effects of histamine, bradykinin and morphine on adrenaline secretion from rat adrenal gland were investigated by means… 
1972
1972
A model is described for the study of factors affecting hemostasis. It consists of a Teflon extension of the carotid artery of… 
Review
1972
Review
1972
"Das initiale fettfreie Odem" has been long known by the German school as the initial stage of human atherosclerosis, and a… 
1971
1971
A histoenzymatic study was carried out to elucidate the anti‐atherosclerotic effect of estrogen and pyridinolcarbamate, which has… 
1971
1971
The antiatherosclerotic effects of pyridinolcarbamate and estrogen, both of which have a preventative effect against acute… 
1969
1969
  • T. Shimamoto
  • Acta pathologica japonica
  • 1969
  • Corpus ID: 33089807
Electron microscopical analysis of endothelial linings of the aortic lumen and of the vasa vasorum was made in man, rhesus monkey… 
Highly Cited
1966